Scenarios that move KOD

Kodiak Sciences Inc - Common Stock

Scenarios that move KOD: 2 analyses, 1 positive, 1 negative.

  1. · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -52 · confidence low · horizon weeks
  2. · Kodiak Sciences shares soar 178% on positive wet AMD data — ▲ · impact +95 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing